TMCnet News
Research and Markets: Global Protein Therapeutics Market Outlook 2018DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/3tq942/global_protein) has announced the addition of the "Global Protein Therapeutics Market Outlook 2018" report to their offering. Protein based therapies have found a prominent place in the biopharmaceutical industry since the launch of the human insulin product. They have become one of the most effective clinical methods to treat a wide spectrum of diseases ranging from cancer to metabolic disorders. The market holds tremendous potential for future growth and it is estimated that by the end of 2018, it may reach the mark of US$ 165 Billion as new products (especially monoclonal antibodies in the advanced clinical phase) may enter the sector. According to this new research report, Global Protein Therapeutics Market Outlook 2018, a large number of market players has been developing monoclonal antibodies (mAbs). This research has found that mAbs contribute the largest shares in the number of protein therapeutic products under pipeline. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments. Through in-depth and prudent analysis of the developments taking place at the global level, the authors have observed that te US holds a dominant position in the global protein therapeutics market as the country provides a major proportion of the products' sales. However, the researchers for this report have come up with an analysis that the future landscape of the market may find positive developments from Asian countries as huge patients' population and increasing disposable incomes may turn out to be a win-win condition for industry participants. The report also covers an advanced phase drug analysis. This chapter lists all the protein therapeutics of the major players which are in the third phase of the clinical trial. This analysis will help the client in understanding the potential market for the future. It also helps understand the major segments, indications and players in Protein Therapeutics that will continue to rule the market. The report takes into account all the key aspects of the worldwide protein therapeutics market and projects the market during the period 2012-2018. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performances and last but not the least, current and future market sizes. Moreover, the report provides a summary of the recent trends that may have an impact on the future industry performance. At the end, the key players of the market have been enlisted. A brief business overview of every player has been provided along with its product portfolio. This is followed by the recent developments of the player that may impact the market in the future. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Protein Therapeutics Market 4. Industry Performance 5. Advanced Phase Drugs Analysis 6. Emerging Market Trends 7. Key Players List of Tables List of Charts Companies Mentioned - Abbott Laboratories - Amgen Inc. - Biogen Idec Inc. - Eli Lilly & Company - Johnson & Johnson - Merck Serono S.A. - Novo Nordisk - Pfizer - Roche Group - Sanofi-Aventis For more information visit http://www.researchandmarkets.com/research/3tq942/global_protein About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
